| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adaptor Proteins, Vesicular Transport | 24 | 2017 | 62 | 5.360 |
Why?
|
| ras Proteins | 12 | 2021 | 102 | 5.310 |
Why?
|
| Signal Transduction | 31 | 2022 | 2689 | 2.350 |
Why?
|
| Neoplasms | 9 | 2021 | 1664 | 2.130 |
Why?
|
| Antineoplastic Agents | 5 | 2021 | 1070 | 2.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2022 | 78 | 1.910 |
Why?
|
| Endocytosis | 13 | 2016 | 113 | 1.850 |
Why?
|
| Mutation | 11 | 2022 | 1213 | 1.720 |
Why?
|
| Neuroblastoma | 6 | 2021 | 109 | 1.350 |
Why?
|
| Ubiquitin | 6 | 2009 | 74 | 1.290 |
Why?
|
| ErbB Receptors | 7 | 2013 | 239 | 1.260 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 332 | 1.240 |
Why?
|
| Molecular Targeted Therapy | 3 | 2021 | 170 | 1.010 |
Why?
|
| Animals | 47 | 2022 | 20880 | 1.000 |
Why?
|
| Protein Multimerization | 4 | 2018 | 71 | 0.990 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 3 | 2013 | 5 | 0.950 |
Why?
|
| Biological Products | 2 | 2022 | 78 | 0.920 |
Why?
|
| Down Syndrome | 4 | 2016 | 120 | 0.910 |
Why?
|
| Cell Membrane | 6 | 2020 | 524 | 0.890 |
Why?
|
| Nucleotides | 2 | 2022 | 29 | 0.870 |
Why?
|
| Genes, ras | 2 | 2022 | 46 | 0.860 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 223 | 0.830 |
Why?
|
| Mice | 26 | 2022 | 8474 | 0.800 |
Why?
|
| COS Cells | 12 | 2021 | 155 | 0.790 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 216 | 0.790 |
Why?
|
| Class II Phosphatidylinositol 3-Kinases | 4 | 2015 | 4 | 0.770 |
Why?
|
| Single-Domain Antibodies | 1 | 2021 | 3 | 0.760 |
Why?
|
| Antibodies, Monoclonal | 3 | 2021 | 511 | 0.760 |
Why?
|
| Allosteric Site | 2 | 2020 | 17 | 0.760 |
Why?
|
| Protein Engineering | 1 | 2021 | 35 | 0.750 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 46 | 0.750 |
Why?
|
| Membrane Proteins | 6 | 2022 | 617 | 0.710 |
Why?
|
| Carcinogenesis | 3 | 2022 | 124 | 0.690 |
Why?
|
| Carrier Proteins | 7 | 2011 | 597 | 0.680 |
Why?
|
| Humans | 50 | 2022 | 68549 | 0.650 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 9 | 2013 | 100 | 0.650 |
Why?
|
| Nerve Tissue Proteins | 6 | 2007 | 290 | 0.640 |
Why?
|
| Ubiquitination | 4 | 2020 | 85 | 0.610 |
Why?
|
| Protein Binding | 12 | 2021 | 1027 | 0.600 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2015 | 19 | 0.590 |
Why?
|
| Multigene Family | 3 | 2017 | 93 | 0.590 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2018 | 331 | 0.590 |
Why?
|
| Nuclear Proteins | 3 | 2007 | 271 | 0.570 |
Why?
|
| HEK293 Cells | 7 | 2021 | 326 | 0.560 |
Why?
|
| src Homology Domains | 8 | 2015 | 29 | 0.550 |
Why?
|
| Copper-transporting ATPases | 3 | 2021 | 6 | 0.540 |
Why?
|
| Transcription Factors | 5 | 2011 | 753 | 0.540 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 108 | 0.540 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 331 | 0.500 |
Why?
|
| Vesicular Transport Proteins | 3 | 2005 | 87 | 0.490 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2011 | 214 | 0.490 |
Why?
|
| Alzheimer Disease | 3 | 2016 | 565 | 0.470 |
Why?
|
| GTP Phosphohydrolases | 5 | 2022 | 46 | 0.460 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2012 | 235 | 0.460 |
Why?
|
| Phosphotyrosine | 4 | 2000 | 41 | 0.450 |
Why?
|
| Peptides | 4 | 2015 | 455 | 0.440 |
Why?
|
| DNA-Binding Proteins | 4 | 2003 | 700 | 0.440 |
Why?
|
| Mitogens | 3 | 2001 | 45 | 0.430 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 30 | 0.410 |
Why?
|
| Cell Line, Tumor | 7 | 2022 | 1851 | 0.410 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1293 | 0.400 |
Why?
|
| Cell Line | 10 | 2012 | 1752 | 0.400 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 62 | 0.380 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 200 | 0.370 |
Why?
|
| Neuropeptides | 3 | 2002 | 106 | 0.370 |
Why?
|
| Trans-Activators | 1 | 2012 | 237 | 0.370 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 261 | 0.360 |
Why?
|
| Allosteric Regulation | 2 | 2020 | 58 | 0.360 |
Why?
|
| Protein Transport | 4 | 2018 | 280 | 0.350 |
Why?
|
| Proteins | 7 | 2004 | 473 | 0.350 |
Why?
|
| Protein Isoforms | 4 | 2016 | 246 | 0.340 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 140 | 0.340 |
Why?
|
| Oncogene Proteins | 5 | 1999 | 35 | 0.340 |
Why?
|
| Molecular Sequence Data | 12 | 2015 | 1446 | 0.330 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 320 | 0.330 |
Why?
|
| Amino Acid Sequence | 10 | 2015 | 1082 | 0.330 |
Why?
|
| Superoxide Dismutase | 2 | 2020 | 149 | 0.320 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2009 | 89 | 0.320 |
Why?
|
| Neurons | 5 | 2021 | 881 | 0.320 |
Why?
|
| Phosphorylation | 12 | 2018 | 1200 | 0.320 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2019 | 284 | 0.320 |
Why?
|
| Motor Activity | 1 | 2011 | 621 | 0.310 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 160 | 0.310 |
Why?
|
| Huntington Disease | 1 | 2007 | 15 | 0.300 |
Why?
|
| Enzyme Activation | 5 | 2015 | 791 | 0.290 |
Why?
|
| Protein Subunits | 1 | 2007 | 99 | 0.290 |
Why?
|
| Cells, Cultured | 10 | 2021 | 2673 | 0.290 |
Why?
|
| Structure-Activity Relationship | 4 | 2017 | 420 | 0.290 |
Why?
|
| Heart | 1 | 2012 | 850 | 0.290 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2012 | 28 | 0.280 |
Why?
|
| Cell Proliferation | 3 | 2022 | 1174 | 0.270 |
Why?
|
| Caveolin 1 | 2 | 2020 | 59 | 0.270 |
Why?
|
| Myocardium | 1 | 2012 | 1204 | 0.260 |
Why?
|
| Epidermal Growth Factor | 3 | 2013 | 95 | 0.250 |
Why?
|
| Brain | 2 | 2011 | 2176 | 0.250 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 250 | 0.250 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2007 | 376 | 0.250 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 48 | 0.250 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 42 | 0.250 |
Why?
|
| Cell Survival | 1 | 2007 | 901 | 0.240 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2004 | 2 | 0.240 |
Why?
|
| Cell Differentiation | 6 | 2021 | 1034 | 0.240 |
Why?
|
| Cardiomegaly | 2 | 2015 | 213 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2003 | 411 | 0.230 |
Why?
|
| Leukemia | 2 | 2022 | 117 | 0.230 |
Why?
|
| Kidney | 2 | 2005 | 945 | 0.220 |
Why?
|
| MAP Kinase Signaling System | 4 | 2022 | 247 | 0.220 |
Why?
|
| Gene Silencing | 2 | 2017 | 137 | 0.210 |
Why?
|
| Mice, Knockout | 6 | 2021 | 1692 | 0.210 |
Why?
|
| Binding Sites | 5 | 2005 | 631 | 0.210 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 1033 | 0.200 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 37 | 0.200 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2011 | 195 | 0.200 |
Why?
|
| Base Sequence | 7 | 2011 | 1015 | 0.200 |
Why?
|
| Peptide Fragments | 1 | 2004 | 483 | 0.200 |
Why?
|
| P-type ATPases | 1 | 2021 | 1 | 0.200 |
Why?
|
| Clathrin | 2 | 2000 | 17 | 0.200 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 562 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 32 | 0.190 |
Why?
|
| Mutant Proteins | 1 | 2021 | 45 | 0.190 |
Why?
|
| Acetonitriles | 1 | 2020 | 6 | 0.190 |
Why?
|
| Metabolism | 1 | 2020 | 12 | 0.190 |
Why?
|
| Blood Vessels | 1 | 2021 | 102 | 0.190 |
Why?
|
| Endothelial Cells | 2 | 2021 | 384 | 0.190 |
Why?
|
| Dimerization | 1 | 2020 | 99 | 0.190 |
Why?
|
| Molecular Conformation | 1 | 2020 | 128 | 0.180 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2020 | 41 | 0.180 |
Why?
|
| 3T3 Cells | 7 | 2001 | 124 | 0.180 |
Why?
|
| Catalytic Domain | 1 | 2020 | 99 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 304 | 0.180 |
Why?
|
| Alternative Splicing | 2 | 2019 | 93 | 0.180 |
Why?
|
| Drug Design | 1 | 2020 | 107 | 0.180 |
Why?
|
| Oncogenes | 1 | 2020 | 71 | 0.180 |
Why?
|
| DNA Primers | 3 | 2011 | 302 | 0.180 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 163 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 245 | 0.170 |
Why?
|
| Protein Conformation | 1 | 2020 | 362 | 0.170 |
Why?
|
| Xenopus | 3 | 2006 | 30 | 0.170 |
Why?
|
| Pyrimidines | 1 | 2020 | 178 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 53 | 0.170 |
Why?
|
| Autophagy | 1 | 2021 | 208 | 0.170 |
Why?
|
| Piperazines | 1 | 2020 | 206 | 0.170 |
Why?
|
| Mice, Nude | 2 | 2021 | 294 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 2791 | 0.160 |
Why?
|
| Pyridines | 1 | 2020 | 261 | 0.160 |
Why?
|
| Drosophila | 3 | 2007 | 37 | 0.160 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2015 | 93 | 0.150 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 136 | 0.150 |
Why?
|
| RNA Interference | 3 | 2021 | 266 | 0.150 |
Why?
|
| Transplantation, Heterologous | 2 | 2021 | 122 | 0.150 |
Why?
|
| Gene Expression | 5 | 2012 | 770 | 0.150 |
Why?
|
| Huntingtin Protein | 2 | 2007 | 5 | 0.150 |
Why?
|
| ets-Domain Protein Elk-1 | 3 | 2003 | 14 | 0.150 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2016 | 7 | 0.140 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 65 | 0.140 |
Why?
|
| Drug Discovery | 1 | 2017 | 94 | 0.140 |
Why?
|
| Lung Injury | 1 | 2016 | 38 | 0.140 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 203 | 0.140 |
Why?
|
| Protein Kinases | 1 | 2016 | 122 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 317 | 0.130 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 371 | 0.130 |
Why?
|
| Models, Molecular | 1 | 2017 | 546 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 1996 | 173 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 195 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2020 | 69 | 0.130 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2015 | 4 | 0.130 |
Why?
|
| Recombinant Proteins | 3 | 2011 | 742 | 0.130 |
Why?
|
| Amino Acid Motifs | 2 | 2007 | 77 | 0.120 |
Why?
|
| Isoenzymes | 2 | 2015 | 308 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 196 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 786 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 4 | 2004 | 492 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2016 | 219 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 756 | 0.110 |
Why?
|
| Rats | 6 | 2015 | 5300 | 0.110 |
Why?
|
| Shc Signaling Adaptor Proteins | 5 | 2004 | 26 | 0.110 |
Why?
|
| Leukemia, Myeloid | 2 | 1994 | 39 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 371 | 0.110 |
Why?
|
| Phosphatidylinositols | 1 | 2012 | 40 | 0.100 |
Why?
|
| Point Mutation | 1 | 2012 | 97 | 0.100 |
Why?
|
| Intellectual Disability | 1 | 2013 | 114 | 0.100 |
Why?
|
| Ventricular Myosins | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 40 | 0.100 |
Why?
|
| Chromones | 1 | 2012 | 33 | 0.100 |
Why?
|
| Creatine Kinase | 1 | 2012 | 46 | 0.100 |
Why?
|
| Tetracycline | 1 | 2012 | 29 | 0.100 |
Why?
|
| Molecular Chaperones | 2 | 2020 | 81 | 0.100 |
Why?
|
| Myosin Heavy Chains | 1 | 2012 | 49 | 0.100 |
Why?
|
| Morpholines | 1 | 2012 | 79 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 57 | 0.100 |
Why?
|
| Models, Biological | 3 | 2006 | 981 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 137 | 0.100 |
Why?
|
| Sequence Alignment | 2 | 2007 | 165 | 0.100 |
Why?
|
| Biolistics | 1 | 2011 | 5 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 204 | 0.100 |
Why?
|
| Onions | 1 | 2011 | 4 | 0.100 |
Why?
|
| Arabidopsis Proteins | 1 | 2011 | 13 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 442 | 0.100 |
Why?
|
| Organ Size | 1 | 2012 | 242 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2550 | 0.100 |
Why?
|
| Arabidopsis | 1 | 2011 | 20 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 142 | 0.090 |
Why?
|
| Disease | 1 | 2010 | 41 | 0.090 |
Why?
|
| Conserved Sequence | 2 | 2004 | 67 | 0.090 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 765 | 0.090 |
Why?
|
| Proteolysis | 2 | 2021 | 97 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 1991 | 248 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2013 | 342 | 0.090 |
Why?
|
| Female | 7 | 2021 | 38021 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 614 | 0.090 |
Why?
|
| Neurons, Afferent | 2 | 2000 | 32 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 2000 | 357 | 0.090 |
Why?
|
| Mesenteric Arteries | 2 | 2020 | 29 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2011 | 954 | 0.080 |
Why?
|
| Vasodilation | 2 | 2020 | 85 | 0.080 |
Why?
|
| Echocardiography | 1 | 2012 | 515 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1085 | 0.080 |
Why?
|
| Phenotype | 1 | 2011 | 946 | 0.080 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 4 | 2004 | 15 | 0.080 |
Why?
|
| Male | 6 | 2021 | 37283 | 0.080 |
Why?
|
| Epistasis, Genetic | 1 | 2007 | 32 | 0.080 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2006 | 3 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 337 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 807 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 132 | 0.070 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2005 | 2 | 0.060 |
Why?
|
| Infant | 1 | 2011 | 2891 | 0.060 |
Why?
|
| Transfection | 2 | 2004 | 782 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2011 | 3187 | 0.060 |
Why?
|
| Ataxin-3 | 1 | 2004 | 4 | 0.060 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2004 | 7 | 0.060 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2004 | 8 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 322 | 0.060 |
Why?
|
| Calcium Channels, N-Type | 1 | 2004 | 7 | 0.060 |
Why?
|
| Receptors, GABA-B | 1 | 2004 | 10 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2004 | 60 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2004 | 34 | 0.060 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2004 | 5 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2004 | 18 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 69 | 0.060 |
Why?
|
| Sarcoma, Ewing | 1 | 2004 | 26 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 176 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2004 | 152 | 0.060 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 31 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2004 | 182 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2004 | 202 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2000 | 230 | 0.050 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2022 | 33 | 0.050 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2002 | 9 | 0.050 |
Why?
|
| Pituitary Gland | 1 | 2002 | 29 | 0.050 |
Why?
|
| Potassium Channel Blockers | 1 | 2002 | 32 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2002 | 23 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2002 | 37 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2022 | 117 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 1995 | 852 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2002 | 55 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2022 | 242 | 0.050 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2001 | 8 | 0.050 |
Why?
|
| Neural Crest | 1 | 2021 | 58 | 0.050 |
Why?
|
| Neurofibromin 2 | 1 | 2001 | 10 | 0.050 |
Why?
|
| Tretinoin | 1 | 2021 | 92 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 2000 | 81 | 0.050 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 2 | 2 | 2000 | 2 | 0.050 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 3 | 2 | 2000 | 2 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 114 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 56 | 0.050 |
Why?
|
| Zebrafish | 1 | 2021 | 187 | 0.050 |
Why?
|
| Child | 1 | 2011 | 6401 | 0.050 |
Why?
|
| Oocytes | 1 | 2000 | 57 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2021 | 124 | 0.050 |
Why?
|
| Young Adult | 1 | 2011 | 5710 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 213 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2000 | 167 | 0.040 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 1998 | 20 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 219 | 0.040 |
Why?
|
| Recurrence | 1 | 2022 | 948 | 0.040 |
Why?
|
| Plant Proteins | 1 | 1999 | 48 | 0.040 |
Why?
|
| Copper | 1 | 2020 | 149 | 0.040 |
Why?
|
| Aorta | 1 | 2020 | 316 | 0.040 |
Why?
|
| Adolescent | 1 | 2011 | 8904 | 0.040 |
Why?
|
| Transformation, Genetic | 1 | 1998 | 14 | 0.040 |
Why?
|
| Cell Movement | 1 | 2021 | 630 | 0.040 |
Why?
|
| PC12 Cells | 1 | 1998 | 36 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 1998 | 29 | 0.040 |
Why?
|
| Ceramides | 1 | 2022 | 578 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 107 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 597 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 2018 | 30 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 1998 | 75 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1998 | 150 | 0.040 |
Why?
|
| src-Family Kinases | 2 | 2011 | 91 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 1 | 1998 | 128 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 230 | 0.040 |
Why?
|
| Heterografts | 1 | 2017 | 70 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2018 | 2083 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 306 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2020 | 718 | 0.030 |
Why?
|
| Mammals | 1 | 1996 | 47 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 211 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 434 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 539 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2020 | 902 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 181 | 0.030 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2015 | 7 | 0.030 |
Why?
|
| Threonine | 1 | 2015 | 47 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 99 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1995 | 144 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 361 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2015 | 153 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 1991 | 189 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 617 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 1994 | 108 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2015 | 223 | 0.030 |
Why?
|
| Tyrosine | 1 | 2015 | 196 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 1996 | 1663 | 0.030 |
Why?
|
| Ligands | 1 | 2015 | 317 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1995 | 270 | 0.030 |
Why?
|
| Middle Aged | 1 | 2011 | 21119 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 32 | 0.030 |
Why?
|
| Adult | 1 | 2011 | 21379 | 0.030 |
Why?
|
| Baculoviridae | 1 | 1991 | 14 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1991 | 67 | 0.030 |
Why?
|
| Fibronectins | 1 | 1991 | 130 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1991 | 97 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 1990 | 76 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 1990 | 114 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1990 | 144 | 0.020 |
Why?
|
| Breast | 1 | 1990 | 137 | 0.020 |
Why?
|
| Cognition | 1 | 2013 | 512 | 0.020 |
Why?
|
| Tripartite Motif Proteins | 1 | 2009 | 7 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2009 | 94 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 234 | 0.020 |
Why?
|
| Hippocampus | 2 | 2004 | 471 | 0.020 |
Why?
|
| Plasmids | 1 | 2009 | 258 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 215 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 306 | 0.020 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2004 | 5 | 0.010 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2004 | 18 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 88 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2004 | 160 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2004 | 106 | 0.010 |
Why?
|
| Chickens | 1 | 2004 | 232 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 320 | 0.010 |
Why?
|
| ERG1 Potassium Channel | 1 | 2002 | 2 | 0.010 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2002 | 3 | 0.010 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2002 | 25 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 2002 | 22 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2002 | 87 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2001 | 20 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2002 | 204 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1990 | 1533 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2000 | 58 | 0.010 |
Why?
|
| Action Potentials | 1 | 2002 | 223 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 1047 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 1999 | 4 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 929 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1999 | 85 | 0.010 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 1999 | 1 | 0.010 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 1999 | 3 | 0.010 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 1999 | 2 | 0.010 |
Why?
|
| Dynamins | 1 | 1999 | 14 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 89 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1999 | 191 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1999 | 60 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 1998 | 13 | 0.010 |
Why?
|
| Receptor, trkA | 1 | 1998 | 13 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 1998 | 67 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1996 | 100 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 251 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1996 | 379 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 4655 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1996 | 160 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1994 | 11 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1994 | 17 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1994 | 24 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 138 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 1994 | 46 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1994 | 168 | 0.010 |
Why?
|
| Monocytes | 1 | 1994 | 210 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1994 | 489 | 0.010 |
Why?
|
| DNA Probes | 1 | 1990 | 57 | 0.010 |
Why?
|
| Gene Library | 1 | 1990 | 68 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1990 | 71 | 0.010 |
Why?
|